Drug Patents owned by Shilpa

1. Drug name - DOCETAXEL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10842770 SHILPA Non-aqueous taxane pro-emulsion formulations and methods of making and using the same Aug, 2031

(8 years from now)

US9763880 SHILPA Non-aqueous taxane formulations and methods of using the same Sep, 2033

(11 years from now)

US8940786 SHILPA Non-aqueous taxane nanodispersion formulations and methods of using the same Sep, 2033

(11 years from now)

US9308195 SHILPA Non-aqueous taxane formulations and methods of using the same Sep, 2033

(11 years from now)

Drugs and Companies using DOCETAXEL ingredient

Treatment: Method of administering docetaxel to a subject combining the docetaxel pro-emulsion formulation with an aqueous medium to produce docetaxel emulsion; Treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy; treatment of patients with locally advanced squamous cell carcinoma of the head and neck in combination with cisplatin and fluorouracil; use in combination with doxorubicin and cyclophosphamide for adjuvant treatment of patients with operable node-positive breast cancer; treatment of patients with locally advanced metastatic breast cancer after failure of prior chemotherapy; use in combination with cisplatin for treatment of unresectable, locally advanced or metastatic non-small cell lung cancer without prior chemotherapy treatment; treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer in combination with prednisone; treatment of advanced gastric adenocarcinoma in combination with cisplatin and fluorouracil in patients that have not received prior chemotherapy; Method of administering an ethanol-free taxane liquid nanodispersion formulation to a subject combining the formulation with an aqueous medium to provide an ethanol-free taxane diluted solution

Dosage: INJECTABLE;INJECTION

More Information on Dosage
Strength Dosage Availability
20MG/ML (20MG/ML) INJECTABLE;INJECTION Prescription
80MG/4ML (20MG/ML) INJECTABLE;INJECTION Prescription
160MG/8ML (20MG/ML) INJECTABLE;INJECTION Prescription

availability in other generic markets.

Click on the highlighted region to filter.